DrugPatentWatch Database Preview
Intercept Pharms Inc Company Profile
What is the competitive landscape for INTERCEPT PHARMS INC, and when can generic versions of INTERCEPT PHARMS INC drugs launch?
INTERCEPT PHARMS INC has one approved drug.
There are four US patents protecting INTERCEPT PHARMS INC drugs.
There are forty-three patent family members on INTERCEPT PHARMS INC drugs in twenty-four countries and six supplementary protection certificates in five countries.
Summary for Intercept Pharms Inc
| International Patents: | 43 |
| US Patents: | 4 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Intercept Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intercept Pharms Inc | OCALIVA | obeticholic acid | TABLET;ORAL | 207999-002 | May 27, 2016 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Intercept Pharms Inc | OCALIVA | obeticholic acid | TABLET;ORAL | 207999-002 | May 27, 2016 | RX | Yes | Yes | 8,058,267 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Intercept Pharms Inc | OCALIVA | obeticholic acid | TABLET;ORAL | 207999-001 | May 27, 2016 | RX | Yes | No | 8,058,267 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Intercept Pharms Inc | OCALIVA | obeticholic acid | TABLET;ORAL | 207999-002 | May 27, 2016 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Intercept Pharms Inc | OCALIVA | obeticholic acid | TABLET;ORAL | 207999-001 | May 27, 2016 | RX | Yes | No | 9,238,673 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Non-Orange Book US Patents for Intercept Pharms Inc
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 7,786,102 | Steroids as agonists for FXR | ➤ Try a Free Trial |
| 9,732,117 | Steroids as agonists for FXR | ➤ Try a Free Trial |
| 8,969,330 | Steroids as agonists for FXR | ➤ Try a Free Trial |
| 9,732,116 | Preparation and uses of obeticholic acid | ➤ Try a Free Trial |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Intercept Pharms Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| China | 104781272 | ➤ Try a Free Trial |
| Israel | 236231 | ➤ Try a Free Trial |
| Singapore | 10201607230S | ➤ Try a Free Trial |
| India | 2561MUN2014 | ➤ Try a Free Trial |
| Israel | 157816 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Intercept Pharms Inc Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2017 00025 | Denmark | ➤ Try a Free Trial | PRODUCT NAME: OBETICHOLIC ACID; REG. NO/DATE: EU/1/16/1139 20161215 |
| 2017000034 | Germany | ➤ Try a Free Trial | PRODUCT NAME: OBETICHOLSAEURE (OBETICHOLIC ACID); REGISTRATION NO/DATE: EU/1/16/1139 20161212 |
| /2017 | Austria | ➤ Try a Free Trial | PRODUCT NAME: OBETICHOLSAEURE, DESSEN PHARMAZEUTISCH AKZEPTABLEN SALZE, SOLVATE ODER AMINOSAEURE-KONJUGATE; REGISTRATION NO/DATE: EU/1/16/1139 20161212 |
| 90020-0 | Sweden | ➤ Try a Free Trial | PRODUCT NAME: OBETICHOLIC ACID; REG. NO/DATE: EU/1/16/1139 20161215 |
| 0877 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: OBETICHOLZUUR; REGISTRATION NO/DATE: EU/1/16/1139 20161215 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.
